Free Trial

Novo Integrated Sciences (NVOS) Competitors

$0.07 -0.01 (-14.70%)
As of 03:50 PM Eastern

NVOS vs. CYD, SMX, HLP, MOG-A, STRCW, ASML, CARR, JCI, BKR, and SYM

Should you be buying Novo Integrated Sciences stock or one of its competitors? The main competitors of Novo Integrated Sciences include China Yuchai International (CYD), SMX (Security Matters) Public (SMX), Hongli Group (HLP), Moog (MOG-A), Palladyne AI (STRCW), ASML (ASML), Carrier Global (CARR), Johnson Controls International (JCI), Baker Hughes (BKR), and Symbotic (SYM). These companies are all part of the "machinery" industry.

Novo Integrated Sciences vs.

Novo Integrated Sciences (NASDAQ:NVOS) and China Yuchai International (NYSE:CYD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

China Yuchai International received 190 more outperform votes than Novo Integrated Sciences when rated by MarketBeat users.

CompanyUnderperformOutperform
Novo Integrated SciencesN/AN/A
China Yuchai InternationalOutperform Votes
190
57.40%
Underperform Votes
141
42.60%

China Yuchai International has higher revenue and earnings than Novo Integrated Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Integrated Sciences$13.29M0.10-$16.17M-$0.87-0.08
China Yuchai International$2.55B0.00$40.19MN/AN/A

In the previous week, Novo Integrated Sciences' average media sentiment score of 0.00 equaled China Yuchai International'saverage media sentiment score.

Company Overall Sentiment
Novo Integrated Sciences Neutral
China Yuchai International Neutral

Novo Integrated Sciences has a beta of -1.97, indicating that its share price is 297% less volatile than the S&P 500. Comparatively, China Yuchai International has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500.

5.7% of Novo Integrated Sciences shares are held by institutional investors. 10.4% of Novo Integrated Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

China Yuchai International has a net margin of 0.00% compared to Novo Integrated Sciences' net margin of -121.55%. China Yuchai International's return on equity of 0.00% beat Novo Integrated Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Integrated Sciences-121.55% -93.07% -46.28%
China Yuchai International N/A N/A N/A

Summary

China Yuchai International beats Novo Integrated Sciences on 7 of the 10 factors compared between the two stocks.

Get Novo Integrated Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVOS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVOS vs. The Competition

MetricNovo Integrated SciencesEngines & turbines IndustryMedical SectorNASDAQ Exchange
Market Cap$1.33M$5.40B$5.40B$9.13B
Dividend YieldN/A2.63%5.37%4.00%
P/E Ratio-0.0812.4688.8317.53
Price / Sales0.102.521,284.8780.52
Price / CashN/A13.2936.6032.90
Price / Book0.093.034.964.69
Net Income-$16.17M$96.32M$117.89M$224.57M
7 Day PerformanceN/A10.43%2.74%3.33%
1 Month PerformanceN/A23.87%3.63%5.33%
1 Year PerformanceN/A180.92%27.26%22.97%

Novo Integrated Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVOS
Novo Integrated Sciences
N/A$0.07
-14.7%
N/A-87.8%$1.33M$13.29M-0.08170
CYD
China Yuchai International
N/A$10.15
+0.2%
N/A+17.7%$2.74M$2.55B0.008,177Negative News
SMX
SMX (Security Matters) Public
0.1392 of 5 stars
$0.26
-35.2%
N/A-99.2%$765,000.00N/A0.00N/APositive News
Gap Down
HLP
Hongli Group
N/A$1.30
-1.5%
N/A-60.6%$0.00$14.05M0.00207
MOG-A
Moog
N/A$199.63
-1.5%
N/A+46.9%$0.00N/A24.1114,000High Trading Volume
STRCW
Palladyne AI
N/A$0.60
+1.7%
N/A+9,015.4%$0.00N/A0.0070Gap Up
ASML
ASML
4.274 of 5 stars
$727.41
-1.6%
$955.50
+31.4%
-0.2%$286.18B$26.24B38.0842,416Positive News
CARR
Carrier Global
4.8873 of 5 stars
$67.18
+1.0%
$84.36
+25.6%
+24.8%$60.28B$24.80B17.0152,000
JCI
Johnson Controls International
4.5607 of 5 stars
$79.37
+0.9%
$82.21
+3.6%
+50.1%$52.56B$22.95B31.25102,000Short Interest ↑
BKR
Baker Hughes
4.3507 of 5 stars
$44.83
+3.6%
$47.18
+5.2%
+51.6%$44.36B$27.30B20.1055,000
SYM
Symbotic
2.8504 of 5 stars
$24.47
-4.4%
$39.86
+62.9%
-32.5%$14.37B$1.79B-407.831,120Analyst Forecast

Related Companies and Tools


This page (NASDAQ:NVOS) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners